ICU MEDICAL INCDE
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
ICUI$182.11+1.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets at and
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except par value data and treasury shares)
| September 30,2024 · December 31,2023 | |||
|---|---|---|---|
| (Unaudited) | (1) | ||
| ASSETS | |||
| CURRENT ASSETS: | |||
| Cash and cash equivalents | $312,512 | $254,222 | |
| Short-term investment securities | — | 501 | |
| TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENT SECURITIES | 312,512 | 254,723 | |
| Accounts receivable, net of allowance for doubtful accounts $9,553 at September 30, 2024 and $11,064 at December 31, 2023 | 173,983 | 161,566 | |
| Inventories | 692,038 | 709,360 | |
| Prepaid income taxes | 5,787 | 21,983 | |
| Prepaid expenses and other current assets | 73,735 | 73,640 | |
| TOTAL CURRENT ASSETS | 1,258,055 | 1,221,272 | |
| PROPERTY, PLANT AND EQUIPMENT, net | 595,627 | 612,909 | |
| OPERATING LEASE RIGHT-OF-USE ASSETS | 59,757 | 69,909 | |
| GOODWILL | 1,478,293 | 1,472,446 | |
| INTANGIBLE ASSETS, net | 785,823 | 870,588 | |
| DEFERRED INCOME TAXES | 40,646 | 37,295 | |
| OTHER ASSETS | 86,837 | 94,020 | |
| TOTAL ASSETS | $4,305,038 | $4,378,439 | |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||
| CURRENT LIABILITIES: | |||
| Accounts payable | $168,562 | $150,030 | |
| Accrued liabilities | 325,728 | 268,215 | |
| Current portion of long-term debt | 51,000 | 51,000 | |
| Income tax payable | 2,767 | 7,714 | |
| Contingent earn-out liability | 1,500 | 4,879 | |
| TOTAL CURRENT LIABILITIES | 549,557 | 481,838 | |
| CONTINGENT EARN-OUT LIABILITY | — | 3,991 | |
| LONG-TERM DEBT | 1,543,342 | 1,577,770 | |
| OTHER LONG-TERM LIABILITIES | 80,389 | 100,497 | |
| DEFERRED INCOME TAXES | 48,538 | 55,873 | |
| INCOME TAX LIABILITY | 34,625 | 35,060 | |
| COMMITMENTS AND CONTINGENCIES (Note 18) | |||
| STOCKHOLDERS’ EQUITY: | |||
| Convertible preferred stock, $1.00 par value; Authorized — 500 shares; Issued and outstanding — none | — | — | |
| Common stock, $0.10 par value; Authorized — 80,000 shares; Issued — 24,461 shares at September 30, 2024 and 24,144 shares at December 31, 2023; and outstanding — 24,459 shares at September 30, 2024 and 24,141 shares at December 31, 2023 | 2,446 | 2,414 | |
| Additional paid-in capital | 1,394,799 | 1,366,493 | |
| Treasury stock, at cost (1,392 and 2,428 shares, respectively) | (208) | (262) | |
| Retained earnings | 713,986 | 807,846 | |
| Accumulated other comprehensive loss | (62,436) | (53,081) | |
| TOTAL STOCKHOLDERS' EQUITY | 2,048,587 | 2,123,410 | |
| TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $4,305,038 | $4,378,439 | |
(1)December 31, 2023 balances were derived from audited consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.